Infusion of Apomorphine: Long-term Safety Study

Summary

This is a Phase 3, multicenter, open-label, safety and tolerability study of continuous apomorphine infusion in subjects with advanced Parkinson's Disease (PD) whose motor fluctuations remain unsatisfactory with levodopa (or levodopa/carbidopa) and at least one other class of drugs or mode of therapy for PD.

Timeline

Start

2015-02

Primary completion

2018-12

Completion

2025-12

Drugs

Indications